Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 20,677 results that match your search.20,677 results
  • As investment into Latin America increases, protecting famous trade marks becomes more important. Tony Ferguson compares the protection available in Argentina, Uruguay, Paraguay, Brazil and Chile
  • Canada A L 1 (1) Smart & Biggar/Fetherstonhaugh & Co Ottawa ? ? 2 (2) Gowling Lafleur Henderson Ottawa ? ? 3 (5) Ridout & Maybee Toronto ? ? 4 (9) Blake Cassels & Graydon Toronto ? ? 5 (4) Swabey Ogilvy Renault/Ogilvy Renault Montreal ? ? 6 (7) Bereskin & Parr Toronto ? ? 7 (-) MBM & Co Ottawa ? ? 8 (-) MacRae & Co Ottawa ? ? 9 (8) Deeth Williams Wall Toronto ? ? 10 (-) Ade & Company Winnipeg ? ?
  • The Colombian Patent Office denied to grant a patent on an application filed by Pfizer Inc directed to a product known as "Viagra" , whose chemical name is pyrazolepyrimidone. The reason for this decision was that the application was trying to protect a new use of a known product. About the same time, the Peruvian Patent Office granted a patent to a corresponding patent application for the same subject matter.
  • South Africa A L 1 (2) Spoor & Fisher Pretoria ? ? 2 (1) Adams & Adams Pretoria ? ? 3 (4) DM Kisch Johannesburg ? ? 4 (3) John & Kernick/Bowman Gilfillan Halfway House ? ? 5 (-) Hahn & Hahn Pretoria ? ?
  • WIPO has turned the tables on multinational companies with the publication of a draft report on protecting traditional knowledge. The 320-page report covers owners of tradition-based literary, artistic or scientific intellectual activity.
  • A string of high-profile cases has raised the question of where the boundaries of trade mark protection should be drawn. In the first article in a series, a team of correspondents compare trade mark registrability in eight countries from China to Chile
  • Politicians and regulators are responding to competition in the pharmaceutical industry by threatening patent rights. The consequence will be all out war between branded companies and generics. Tabitha Parker reports from the front line
  • John A Tessensohn and Shusaku Yamamoto explain the evolution of a trade mark dispute over the Starbucks logo, and examine the usefulness of Japan's Unfair Competition Prevention Law
  • With the sequencing of the human genome, the question of patenting genes has become front page news. To shed some light on the controversial topic, MIP assembled seven biotech specialists at Taylor Joynson Garrett's offices in London, with telephone and video-links to the US. The wide-ranging debate covered utility, ESTs, examination standards, the role of patents and ethical objections. Chuck Ludlam begins the discussion
  • On Sunday July 16, in Yokahama, Japan, the most significant event since the creation of the internet domain name system was played out. As a finale, the main protagonist, the International Corporation for Assigned Names and Numbers, agreed to extend the number of top-level domain names (TLDs).